Literature DB >> 20623542

Delta-catenin/NPRAP: A new member of the glycogen synthase kinase-3beta signaling complex that promotes beta-catenin turnover in neurons.

Sonja Bareiss1, Kwonseop Kim, Qun Lu.   

Abstract

Through a multiprotein complex, glycogen synthase kinase-3beta (GSK-3beta) phosphorylates and destabilizes beta-catenin, an important signaling event for neuronal growth and proper synaptic function. delta-Catenin, or NPRAP (CTNND2), is a neural enriched member of the beta-catenin superfamily and is also known to modulate neurite outgrowth and synaptic activity. In this study, we investigated the possibility that delta-catenin expression is also affected by GSK-3beta signaling and participates in the molecular complex regulating beta-catenin turnover in neurons. Immunofluorescent light microscopy revealed colocalization of delta-catenin with members of the molecular destruction complex: GSK-3beta, beta-catenin, and adenomatous polyposis coli proteins in rat primary neurons. GSK-3beta formed a complex with delta-catenin, and its inhibition resulted in increased delta-catenin and beta-catenin expression levels. LY294002 and amyloid peptide, known activators of GSK-3beta signaling, reduced delta-catenin expression levels. Furthermore, delta-catenin immunoreactivity increased and protein turnover decreased when neurons were treated with proteasome inhibitors, suggesting that the stability of delta-catenin, like that of beta-catenin, is regulated by proteasome-mediated degradation. Coimmunoprecipitation experiments showed that delta-catenin overexpression promoted GSK-3beta and beta-catenin interactions. Primary cortical neurons and PC12 cells expressing delta-catenin treated with proteasome inhibitors showed increased ubiquitinated beta-catenin forms. Consistent with the hypothesis that delta-catenin promotes the interaction of the destruction complex molecules, cycloheximide treatment of cells overexpressing delta-catenin showed enhanced beta-catenin turnover. These studies identify delta-catenin as a new member of the GSK-3beta signaling pathway and further suggest that delta-catenin is potentially involved in facilitating the interaction, ubiquitination, and subsequent turnover of beta-catenin in neuronal cells. (c) 2010 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20623542      PMCID: PMC3813950          DOI: 10.1002/jnr.22414

Source DB:  PubMed          Journal:  J Neurosci Res        ISSN: 0360-4012            Impact factor:   4.164


  68 in total

1.  Different effects of Alzheimer-associated mutations of presenilin 1 on its processing.

Authors:  O Murayama; T Honda; M Mercken; M Murayama; K Yasutake; N Nihonmatsu; Y Nakazato; G Michel; S Song; K Sato; H Takahashi; A Takashima
Journal:  Neurosci Lett       Date:  1997-06-20       Impact factor: 3.046

2.  Identification and localization of a neurally expressed member of the plakoglobin/armadillo multigene family.

Authors:  R Paffenholz; W W Franke
Journal:  Differentiation       Date:  1997-08       Impact factor: 3.880

3.  Essential roles for GSK-3s and GSK-3-primed substrates in neurotrophin-induced and hippocampal axon growth.

Authors:  Woo-Yang Kim; Feng-Quan Zhou; Jiang Zhou; Yukako Yokota; Yan-Min Wang; Takeshi Yoshimura; Kozo Kaibuchi; James R Woodgett; E S Anton; William D Snider
Journal:  Neuron       Date:  2006-12-21       Impact factor: 17.173

4.  Downregulation of beta-catenin by human Axin and its association with the APC tumor suppressor, beta-catenin and GSK3 beta.

Authors:  M J Hart; R de los Santos; I N Albert; B Rubinfeld; P Polakis
Journal:  Curr Biol       Date:  1998-05-07       Impact factor: 10.834

Review 5.  Judging a protein by more than its name: GSK-3.

Authors:  J R Woodgett
Journal:  Sci STKE       Date:  2001-09-18

6.  Hemizygosity of delta-catenin (CTNND2) is associated with severe mental retardation in cri-du-chat syndrome.

Authors:  M Medina; R C Marinescu; J Overhauser; K S Kosik
Journal:  Genomics       Date:  2000-01-15       Impact factor: 5.736

Review 7.  Signal transduction during amyloid-beta-peptide neurotoxicity: role in Alzheimer disease.

Authors:  Rodrigo A Fuentealba; Ginny Farias; Jessica Scheu; Miguel Bronfman; María Paz Marzolo; Nibaldo C Inestrosa
Journal:  Brain Res Brain Res Rev       Date:  2004-12

8.  Destabilization of beta-catenin by mutations in presenilin-1 potentiates neuronal apoptosis.

Authors:  Z Zhang; H Hartmann; V M Do; D Abramowski; C Sturchler-Pierrat; M Staufenbiel; B Sommer; M van de Wetering; H Clevers; P Saftig; B De Strooper; X He; B A Yankner
Journal:  Nature       Date:  1998-10-15       Impact factor: 49.962

9.  Cloning and characterization of a new armadillo family member, p0071, associated with the junctional plaque: evidence for a subfamily of closely related proteins.

Authors:  M Hatzfeld; C Nachtsheim
Journal:  J Cell Sci       Date:  1996-11       Impact factor: 5.285

10.  delta-catenin, an adhesive junction-associated protein which promotes cell scattering.

Authors:  Q Lu; M Paredes; M Medina; J Zhou; R Cavallo; M Peifer; L Orecchio; K S Kosik
Journal:  J Cell Biol       Date:  1999-02-08       Impact factor: 10.539

View more
  17 in total

1.  Caspase-3 cleavage links delta-catenin to the novel nuclear protein ZIFCAT.

Authors:  Dongmin Gu; Nam Ky Tonthat; Moonsup Lee; Hong Ji; Krishna P Bhat; Faith Hollingsworth; Kenneth D Aldape; Maria A Schumacher; Thomas P Zwaka; Pierre D McCrea
Journal:  J Biol Chem       Date:  2011-05-11       Impact factor: 5.157

2.  14-3-3ε and ζ regulate neurogenesis and differentiation of neuronal progenitor cells in the developing brain.

Authors:  Kazuhito Toyo-oka; Tomoka Wachi; Robert F Hunt; Scott C Baraban; Shinichiro Taya; Hayley Ramshaw; Kozo Kaibuchi; Quenten P Schwarz; Angel F Lopez; Anthony Wynshaw-Boris
Journal:  J Neurosci       Date:  2014-09-03       Impact factor: 6.167

3.  Intra-axonal Synthesis of SNAP25 Is Required for the Formation of Presynaptic Terminals.

Authors:  Andreia F R Batista; José C Martínez; Ulrich Hengst
Journal:  Cell Rep       Date:  2017-09-26       Impact factor: 9.423

4.  Lithium increases synaptic GluA2 in hippocampal neurons by elevating the δ-catenin protein.

Authors:  Mobeen Farooq; Seonil Kim; Sunny Patel; Latika Khatri; Takuya Hikima; Margaret E Rice; Edward B Ziff
Journal:  Neuropharmacology       Date:  2016-10-25       Impact factor: 5.250

5.  δ-Catenin dysregulation in cancer: interactions with E-cadherin and beyond.

Authors:  Qun Lu
Journal:  J Pathol       Date:  2010-10       Impact factor: 7.996

6.  A Mouse Brain-based Multi-omics Integrative Approach Reveals Potential Blood Biomarkers for Ischemic Stroke.

Authors:  Alba Simats; Laura Ramiro; Teresa García-Berrocoso; Ferran Briansó; Ricardo Gonzalo; Luna Martín; Anna Sabé; Natalia Gill; Anna Penalba; Nuria Colomé; Alex Sánchez; Francesc Canals; Alejandro Bustamante; Anna Rosell; Joan Montaner
Journal:  Mol Cell Proteomics       Date:  2020-08-31       Impact factor: 5.911

7.  Common SNPs in myelin transcription factor 1-like (MYT1L): association with major depressive disorder in the Chinese Han population.

Authors:  Ti Wang; Zhen Zeng; Tao Li; Jie Liu; Junyan Li; You Li; Qian Zhao; Zhiyun Wei; Yang Wang; Baojie Li; Guoyin Feng; Lin He; Yongyong Shi
Journal:  PLoS One       Date:  2010-10-27       Impact factor: 3.240

8.  The cross-talk between canonical and non-canonical Wnt-dependent pathways regulates P-glycoprotein expression in human blood-brain barrier cells.

Authors:  Martha L Pinzón-Daza; Iris C Salaroglio; Joanna Kopecka; Ruth Garzòn; Pierre-Olivier Couraud; Dario Ghigo; Chiara Riganti
Journal:  J Cereb Blood Flow Metab       Date:  2014-06-04       Impact factor: 6.200

Review 9.  Genetic alterations of δ-catenin/NPRAP/Neurojungin (CTNND2): functional implications in complex human diseases.

Authors:  Qun Lu; Byron J Aguilar; Mingchuan Li; Yongguang Jiang; Yan-Hua Chen
Journal:  Hum Genet       Date:  2016-07-05       Impact factor: 4.132

10.  Crebinostat: a novel cognitive enhancer that inhibits histone deacetylase activity and modulates chromatin-mediated neuroplasticity.

Authors:  Daniel M Fass; Surya A Reis; Balaram Ghosh; Krista M Hennig; Nadine F Joseph; Wen-Ning Zhao; Thomas J F Nieland; Ji-Song Guan; Chelsea E Groves Kuhnle; Weiping Tang; Douglas D Barker; Ralph Mazitschek; Stuart L Schreiber; Li-Huei Tsai; Stephen J Haggarty
Journal:  Neuropharmacology       Date:  2012-07-04       Impact factor: 5.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.